venetoclax,rituximab,pirtobrutinib
roche,abbvie,eli lilly
['pirto', 'lymphoma', 'mantle,(-dismantle)', 'lymsm', 'bruin']
congress| #asco23 catherine callaghan summarizes long-term safety data of pirtobrutinib in patients with r/r mantle cell lymphoma participating in the bruin trial. the data is consistent with previous findings regardless of follow-up time #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm